Insight Molecular Diagnostics Inc. Operating Cash Flow
Insight Molecular Diagnostics Inc. (IMDX) reported Operating Cash Flow of -$16.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$9.27M.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$7.64M.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.54M.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.63M.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$22.18M.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$20.69M.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$23.32M.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$45.57M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$16.91M 10-Q · filed 2026-08-10 | -$22.45M derived: sum of 3 quarters · filed 2026-08-10 | -$27.08M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$7.64M 10-Q · filed 2026-05-13 | -$13.18M derived: sum of 2 quarters · filed 2026-05-13 | -$17.81M derived: sum of 3 quarters · filed 2026-05-13 | -$23.98M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$5.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$10.17M derived: sum of 2 quarters · filed 2026-03-26 | -$16.34M derived: sum of 3 quarters · filed 2026-08-10 | -$22.18M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | -$4.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$10.80M derived: sum of 2 quarters · filed 2026-08-10 | -$16.64M 10-Q · filed 2025-11-10 | -$21.99M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$6.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$12.01M 10-Q · filed 2026-08-10 | -$12.14M 10-Q · filed 2025-08-11 | -$17.36M derived: sum of 3 quarters · filed 2026-08-10 | -$22.89M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | -$5.84M 10-Q · filed 2026-05-13 | -$5.86M 10-Q · filed 2025-05-12 | -$11.19M derived: sum of 2 quarters · filed 2026-05-13 | -$16.72M derived: sum of 3 quarters · filed 2026-05-13 | -$22.70M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$5.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$10.88M derived: sum of 2 quarters · filed 2026-03-26 | -$16.86M derived: sum of 3 quarters · filed 2026-03-26 | -$20.69M 10-K · filed 2026-03-26 | -$20.71M 10-K · filed 2025-03-24 | |||
| 2024-09-30 | -$5.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$11.51M derived: sum of 2 quarters · filed 2025-11-10 | -$15.34M 10-Q · filed 2025-11-10 | -$15.36M 10-Q · filed 2024-11-12 | -$19.76M derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | -$5.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$9.81M 10-Q · filed 2025-08-11 | -$14.23M derived: sum of 3 quarters · filed 2025-08-11 | -$18.00M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | -$3.83M 10-Q · filed 2025-05-12 | -$8.25M derived: sum of 2 quarters · filed 2025-05-12 | -$12.02M derived: sum of 3 quarters · filed 2025-05-12 | -$18.86M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$8.19M derived: sum of 2 quarters · filed 2025-03-24 | -$15.03M derived: sum of 3 quarters · filed 2025-03-24 | -$23.32M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | -$3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$10.60M derived: sum of 2 quarters · filed 2024-11-12 | -$18.90M 10-Q · filed 2024-11-12 | -$18.76M 10-Q · filed 2023-11-09 | -$28.55M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$6.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$15.13M 10-Q · filed 2024-08-08 | -$16.50M 10-Q · filed 2023-08-10 | -$24.78M derived: sum of 3 quarters · filed 2024-08-08 | -$36.18M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$8.30M 10-Q · filed 2024-05-15 | -$9.67M 10-Q · filed 2023-05-15 | -$17.95M derived: sum of 2 quarters · filed 2024-05-15 | -$29.34M derived: sum of 3 quarters · filed 2024-05-15 | -$40.59M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$9.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$21.04M derived: sum of 2 quarters · filed 2024-04-16 | -$32.29M derived: sum of 3 quarters · filed 2024-04-16 | -$45.57M 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | -$11.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$22.64M derived: sum of 2 quarters · filed 2023-11-09 | -$35.92M 10-Q · filed 2023-11-09 | -$42.98M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$11.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$24.52M 10-Q · filed 2023-08-10 | -$24.57M 10-Q · filed 2022-08-12 | -$31.59M derived: sum of 3 quarters · filed 2023-08-10 | -$42.57M derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | -$13.28M 10-Q · filed 2023-05-15 | -$20.34M derived: sum of 2 quarters · filed 2023-05-15 | -$31.32M derived: sum of 3 quarters · filed 2023-05-15 | -$39.38M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$7.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | -$18.05M derived: sum of 2 quarters · filed 2023-04-12 | -$26.11M derived: sum of 3 quarters · filed 2023-04-12 | -$35.94M 10-K · filed 2023-04-12 | ||||
| 2021-09-30 | -$10.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$19.04M derived: sum of 2 quarters · filed 2022-11-10 | -$28.88M 10-Q · filed 2022-11-10 | -$35.02M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$8.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$17.89M 10-Q · filed 2022-08-12 | -$17.93M 10-Q · filed 2021-08-11 | -$24.04M derived: sum of 3 quarters · filed 2022-08-12 | -$30.04M derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | -$9.84M 10-Q · filed 2022-05-12 | -$9.85M 10-Q · filed 2021-05-17 | -$15.98M derived: sum of 2 quarters · filed 2022-05-12 | -$21.98M derived: sum of 3 quarters · filed 2022-05-12 | -$28.95M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | -$6.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$12.15M derived: sum of 2 quarters · filed 2022-03-11 | -$19.11M derived: sum of 3 quarters · filed 2022-03-11 | -$25.98M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | -$6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$12.97M derived: sum of 2 quarters · filed 2021-11-09 | -$19.84M 10-Q · filed 2021-11-09 | -$19.83M 10-Q · filed 2020-11-12 | -$25.14M derived: sum of 4 quarters · filed 2021-11-09 | |||
| 2020-06-30 | -$6.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$13.83M 10-Q · filed 2021-08-11 | -$13.87M 10-Q · filed 2020-07-29 | -$19.14M derived: sum of 3 quarters · filed 2021-08-11 | -$23.99M derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | -$6.87M 10-Q · filed 2021-05-17 | -$12.18M derived: sum of 2 quarters · filed 2021-05-17 | -$17.03M derived: sum of 3 quarters · filed 2021-05-17 | -$19.87M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | -$5.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | -$10.16M derived: sum of 2 quarters · filed 2021-03-19 | -$13.00M derived: sum of 3 quarters · filed 2021-03-19 | -$19.71M 10-K · filed 2021-03-19 | ||||
| 2019-09-30 | -$4.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$7.69M derived: sum of 2 quarters · filed 2020-11-12 | -$14.41M 10-Q · filed 2020-11-12 | -$16.86M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | -$2.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$9.56M 10-Q · filed 2020-07-29 | -$12.01M derived: sum of 3 quarters · filed 2020-07-29 | -$14.50M derived: sum of 4 quarters · filed 2020-07-29 | ||||
| 2019-03-31 | -$6.72M 10-Q · filed 2020-05-12 | -$9.17M derived: sum of 2 quarters · filed 2020-05-12 | -$11.66M derived: sum of 3 quarters · filed 2020-05-12 | -$15.61M derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | -$2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$4.94M derived: sum of 2 quarters · filed 2020-03-26 | -$8.90M derived: sum of 3 quarters · filed 2020-03-26 | -$11.65M 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | -$2.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$6.44M derived: sum of 2 quarters · filed 2019-11-14 | -$9.19M 10-Q · filed 2019-11-14 | -$12.54M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$3.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$6.71M 10-Q · filed 2019-08-14 | -$10.05M derived: sum of 3 quarters · filed 2019-08-14 | -$13.52M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | -$2.75M 10-Q · filed 2019-05-14 | -$6.10M derived: sum of 2 quarters · filed 2019-05-14 | -$9.57M derived: sum of 3 quarters · filed 2019-05-14 | -$12.85M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$6.81M derived: sum of 2 quarters · filed 2019-04-01 | -$10.10M derived: sum of 3 quarters · filed 2019-04-01 | -$13.38M 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | -$3.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$6.75M derived: sum of 2 quarters · filed 2018-11-13 | -$10.04M 10-Q · filed 2018-11-13 | -$12.55M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$6.57M 10-Q · filed 2018-08-14 | -$9.09M derived: sum of 3 quarters · filed 2018-08-14 | -$10.12M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | -$3.29M 10-Q · filed 2018-05-15 | -$5.80M derived: sum of 2 quarters · filed 2018-05-15 | -$6.84M derived: sum of 3 quarters · filed 2018-05-15 | |||||
| 2016-12-31 | -$2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$3.55M derived: sum of 2 quarters · filed 2018-04-02 | -$7.52M 10-K · filed 2018-04-02 | |||||
| 2016-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$5.01M 10-Q · filed 2017-11-14 | ||||||
| 2016-06-30 | -$3.97M 10-Q · filed 2017-08-14 | |||||||
| 2015-12-31 | -$4.23M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |